The Meaning of the 20% Credit Rate (Post-2030)
The "Post-2030 20% Credit Rate" signifies a legislative simplification of the Arizona R&D tax credit, transitioning from a tiered system (24% on first $2.5M, 15% thereafter) to a single flat 20% rate on all Qualified Research Expenses (QREs).
Detailed Executive Analysis
Historically, Arizona has incentivized innovation through a tiered structure designed to heavily benefit small-to-mid-sized R&D spenders. Currently (pre-2030), companies claim a 24% credit on expenses up to $2.5 million and 15% on expenses exceeding that threshold.
The legislative adjustment taking full effect for tax years beginning after December 31, 2030, eliminates this tier. The new 20% Flat Rate creates a "winner and loser" dynamic: smaller R&D spenders (under $2.5M) will see an effective rate reduction (24% → 20%), while massive R&D spenders (multi-million dollar programs) will see an effective rate increase on their marginal spend (15% → 20%). This move aligns Arizona more closely with federal simplification efforts while maintaining a highly competitive effective tax rate compared to neighboring states.
Interactive Impact Analysis
Use this tool to simulate the financial impact of the law change on your specific R&D expenditure. Visualize the "Crossover Point" where the new flat rate becomes more beneficial than the old tiered system.
⚙ Configuration
Enter your annual Arizona QRE.
Your Results
Credit Yield Comparison Curve
Chart dynamically renders credit amount (Y) vs Spend (X). The intersection represents the fiscal neutrality point.
Revenue Office Guidance
The Arizona Department of Revenue (ADOR) bases its guidance on A.R.S. § 43-1168. Taxpayers must be aware that the definition of "Qualified Research" adheres strictly to the federal IRC § 41 definition, but the computation methodology diverges at the state level.
- 1 Form 308 (Corporate): Post-2030 filings will require a revised Form 308. The current schedule, which separates expenses into "Column A (Up to $2.5M)" and "Column B (Excess)," will be simplified to a single column calculation.
- 2 Carryforward Provisions: Under A.R.S. § 43-1168(D), unused credits can typically be carried forward for 15 consecutive taxable years. The rate change does not retroactively alter the value of credits carried forward from pre-2030 years; they retain their original generated value.
- 3 Refundability Cap: For qualified small businesses (under 150 FTEs), 75% of the excess credit is refundable. The 20% rate change affects the total available credit, which directly impacts the maximum refund claimable.
Case Example: TechNova AZ
Scenario: $4,000,000 in QRE
Current Law (Tiered)
Post-2030 Law (Flat 20%)
Strategic Conclusion
The shift to a 20% flat credit rate post-2030 represents a modernization of Arizona's tax code. While it simplifies compliance and calculation, it necessitates a strategic review for R&D-heavy firms. Companies spending under $7M annually generally face a reduction in benefits, while ultra-high volume spenders may eventually find the flat rate advantageous. Future tax planning must account for this shift in the cost-benefit analysis of Arizona-based research operations.
Strategic Tax Planning: Decoding the Post-2030 Arizona R&D Credit Rate Shift and Compliance Imperatives (A.R.S. § 43-1168)
Section 1: Executive Summary: The Post-2030 Rate Transition
For taxable years beginning on or after January 1, 2031, the Arizona R&D tax credit rate for the first $2.5 million of incremental qualified research expenses (QREs) is scheduled to decrease from 24% to 20%. This change initiates a broader reduction in the credit’s overall value, impacting strategic R&D investment decisions and long-term tax modeling for corporations operating within Arizona.
Detailed Overview of the Statutory Shift
The Arizona Research and Development (R&D) Tax Credit is authorized under Arizona Revised Statutes (A.R.S.) § 43-1168 and serves as a major incentive for businesses engaging in qualified research activities within the state, often focused on sectors like technology, biotechnology, and manufacturing.1 The computation of this credit is rooted in the federal methodology, specifically Section 41 of the Internal Revenue Code (IRC), though specific rates and requirements are governed by state law.2
The Arizona credit utilizes a tiered structure applied to the “excess” of qualified research expenses (QREs) over a predetermined base amount, which must be computed using either the Regular or Alternative Simplified Credit (ASC) method.1
Currently, for taxable years beginning before December 31, 2030, the structure provides highly competitive rates:
- Tier 1: 24% of the sum of excess QREs and basic research payments, if that sum is $2,500,000 or less.2
- Tier 2: 15% of any amount exceeding the initial $2,500,000 threshold.4
The scheduled statutory shift, as laid out in A.R.S. § 43-1168, dictates a significant reduction for taxable years beginning from and after December 31, 2030. The rates are set to decrease as follows 2:
- Post-2030 Tier 1: 20% on the sum up to $2,500,000.2
- Post-2030 Tier 2: 11% on the amount exceeding $2,500,000.2
Financial Impact Modeling
The transition from the 24%/15% rates to the 20%/11% rates initiates a mandatory structural reduction in the credit’s financial benefit. The most immediate and significant impact is the fixed loss associated with the first tier of the calculation.
Under the current structure, the maximum credit benefit derived solely from the first $2.5 million of excess QREs is:
$$24\% \times \$2,500,000 = \$600,000$$
Post-2030, this maximum Tier 1 benefit is reduced:
$$20\% \times \$2,500,000 = \$500,000$$
This represents a fixed $\$100,000$ reduction in the credit amount for every company whose excess QREs meet or exceed the $2.5 million threshold.2 This loss of $\$100,000$ is not a marginal percentage decrease but a fixed financial loss that affects the baseline calculation for all medium and large claimants, necessitating adjustments in long-term tax provision models and financial projections starting with the 2031 tax year. This financial restriction is further compounded by the reduction in the marginal rate for expenses above the threshold.
Section 2: Statutory Framework and Legislative Intent
Reliance on Federal Law and the Incrementality Principle
The Arizona R&D tax credit is fundamentally an incremental credit, meaning it incentivizes increased research activity over a historical base period. The credit is allowed against taxes imposed by Title 43 in an amount determined pursuant to IRC Section 41.2 This adoption means Arizona relies on federal definitions for Qualified Research Expenses (QREs), the structure for calculating the Base Amount, and methodologies like the Regular Method or Alternative Simplified Credit (ASC).1
However, A.R.S. § 43-1168 imposes a key restriction: Qualified research only includes research activities conducted in this state, including research paid for by the taxpayer at a university under the jurisdiction of the Arizona board of regents.2 Furthermore, the termination provisions of federal IRC § 41 do not apply to the Arizona credit, ensuring its permanent availability.2
Legislative History and the Scheduled Step-Down (A.R.S. § 43-1168)
The current high rates (24% and 15%) are the result of legislative action that deferred an earlier scheduled reduction. Measures, such as those detailed in HB 2771, extended the existing corporate credit rates of 15% and 24% from Tax Year (TY) 2021 through TY 2030.7 These legislative measures delayed the corporate credit rates of 11% and 20%, which were originally scheduled to take effect earlier, until Tax Year 2031.7
This legislative history confirms that the rate reduction is not a contingency but a scheduled statutory transition, triggered precisely for “taxable years beginning from and after December 31, 2030”.2
Carryforward Compression: A Strategy of Cost Control
Concurrent with the scheduled rate reduction, the legislature also revised the carryforward provisions. For credits claimed for taxable years beginning before January 1, 2022, the carryforward period was 15 consecutive taxable years.8 However, for credits generated from and after December 31, 2021, the carryforward period was reduced to 10 consecutive taxable years.7
This legislative activity—simultaneously reducing the credit magnitude post-2030 and shortening the carryforward utilization window post-2021—indicates a strategy of state cost containment. By compressing the carryforward period, the state limits its long-term liability and forces companies to utilize the generated credits faster or risk expiration.7 This structural tightening pressures companies to maximize credit generation and utilization prior to the 2031 rate shift, as the value of the credit (24%/15%) is higher in the near term, but the utilization window (10 years) is now shorter than in previous years.
Section 3: Analysis of the Post-2030 Tiered Credit Structure
The shift to the 20%/11% structure materially alters the economic value proposition of the Arizona R&D tax credit, particularly for high-volume claimants.
The 20% Credit Rate: Tier 1 Calculation
The 20% rate applies to the first tier of the calculation, covering the sum of the excess QREs and basic research payments up to the $2,500,000 threshold.2 Taxpayers with sufficient excess QREs to meet or exceed this threshold will receive a maximum credit of $500,000 for this portion.5
This amount, $\$500,000$, serves as the new fixed baseline credit component for large R&D performers starting in 2031, replacing the current fixed baseline of $\$600,000$.5
The Marginal 11% Rate: Tier 2 Calculation
If the total calculated amount (excess QREs plus basic research payments) surpasses $2,500,000, the remaining amount is subject to the Tier 2 rate.2 Post-2030, this Tier 2 rate is reduced to 11%.2
The total credit calculation for claims exceeding the threshold will be the $500,000 fixed baseline plus 11% of the excess amount over $2,500,000.5 The 4-percentage-point drop in the marginal rate (from 15% to 11%) represents a significant reduction in the marginal return on R&D investments beyond the initial tier. This reduction disproportionately affects taxpayers with major, sustained R&D activities within Arizona.
The structural changes are summarized below:
Arizona R&D Credit Rate Structure: Pre- and Post-2030 Comparison
| Taxable Years | Excess QREs ≤ $2.5 Million (Tier 1 Rate) | Maximum Tier 1 Credit (Fixed Baseline) | Excess QREs > $2.5 Million (Tier 2 Rate) | Tier 2 Calculation Formula |
| Before December 31, 2030 | 24% | $600,000 | 15% | $600,000 + 15% of amount > $2.5M 2 |
| From and After December 31, 2030 | 20% | $500,000 | 11% | $500,000 + 11% of amount > $2.5M 2 |
Section 4: Arizona Revenue Office Guidance and Compliance Requirements
Administration of the Arizona R&D tax credit involves a multi-agency compliance process overseen by the Arizona Commerce Authority (ACA) and the Arizona Department of Revenue (ADOR).
The Dual-Agency Administrative Mandate
Taxpayers cannot simply claim the credit on their tax returns; they must navigate a two-step process:
- ACA Certification: The taxpayer must first apply to the Arizona Commerce Authority (ACA) for qualification, particularly if seeking the refundable portion, pursuant to A.R.S. § 41-1507.2 The ACA issues a Certificate of Qualification.9
- ADOR Claim: The taxpayer must submit a copy of the ACA’s Certificate of Qualification along with their income tax return to the ADOR.2 Corporate taxpayers and partnerships complete ADOR Form 308, and individuals complete Form 308-I, to calculate and claim the credit.9 S Corporations and partnerships must also complete allocation forms (308-S or 308-P) for shareholders or partners.9
A critical element of compliance revolves around the impending rate change. ADOR forms, such as the 2024 version of Form 308, currently detail the calculation using the 24% and 15% rates, specifying the $600,000 fixed component.11 For the 2031 tax year, ADOR will be required to update these instructional forms and calculations to reflect the new 20%/11% logic and the $\$500,000$ fixed breakpoint.5 Taxpayers must ensure they use the correct, updated form version for the 2031 filing. Using older forms, which implicitly utilize the $24\%/15\%$ rate structure, would automatically lead to an overstatement of the claimed credit post-2030, significantly elevating audit exposure.
Refundability and Statewide Limitations
The Arizona R&D credit offers a unique benefit of partial refundability, though eligibility is restricted to qualified small businesses, generally defined as those with fewer than 150 full-time employees.9
The refund amount is statutorily limited to 75% of the amount by which the allowable credit exceeds the taxpayer’s tax liability for the taxable year, or the maximum refund amount certified by the ACA, whichever is less.2 This refundability feature is subject to a strict statewide annual cap of $5,000,000 for the general R&D credit.1
The state also offers an additional, non-refundable credit for basic research payments made to universities under the Arizona Board of Regents (ASU, NAU, UA).13 This university R&D credit, which is 10% of the excess basic research payments, is subject to a separate, aggregate annual cap of $10,000,000 (combined for individual and corporate claimants).2
The scheduled rate reduction creates a unique temporal pressure for qualified small businesses. The economic value of the cash refund derived from the credit drops materially starting in 2031. For instance, a maximum first-tier refundable credit pre-2031 is $75\% \times \$600,000 = \$450,000$. Post-2031, this drops to $75\% \times \$500,000 = \$375,000$. This $\$75,000$ difference in potential cash flow benefit provides a strong economic incentive for small businesses to accelerate R&D spending into 2030 to maximize the high-rate refund before the shift. This likely intensifies competitive demand on the fixed $\$5$ million annual refund cap during the 2030 application period, increasing the risk that the cap will be exhausted early, leaving some businesses unable to obtain the refundable portion of their accrued credit.
Section 5: Practical Application: Detailed Post-2030 Calculation Example
To quantify the financial impact, consider the following scenario for TechCo, a large corporation with substantial R&D expenditure in Arizona.
Scenario Parameters (TechCo)
- Current Year Arizona QREs (2031): $15,000,000
- Calculated Base Amount (using Regular or ASC Method): $10,000,000
- Total Excess QREs: $5,000,000 (Calculated as Current QREs minus Base Amount)
Comparative Calculation: Pre-2031 vs. Post-2031 Rates
The calculation demonstrates the mandatory loss in credit value resulting from the statutory rate change.
Comparative R&D Credit Calculation
| Calculation Steps | Pre-2031 Rate (24%/15%) | Credit Amount | Post-2031 Rate (20%/11%) | Credit Amount |
| 1. QREs Subject to Tier 1 Rate (up to $2.5M) | $2,500,000 @ 24% | $600,000 | $2,500,000 @ 20% | $500,000 |
| 2. QREs Subject to Tier 2 Rate (over $2.5M) | $2,500,000 @ 15% | $375,000 | $2,500,000 @ 11% | $275,000 |
| 3. Total Arizona R&D Credit | N/A | $975,000 | N/A | $775,000 |
| Net Loss in Tax Benefit (20.5% Reduction) | N/A | N/A | N/A | ($200,000) |
Analysis of the Credit Reduction
In this example, the statutory rate shift results in a direct loss of $200,000 in tax credit value, representing a significant $20.5\%$ reduction in the state incentive for the same level of R&D investment.
This reduction is structurally derived from two components:
- Tier 1 Fixed Loss: A loss of $\$100,000$ due to the decrease in the baseline calculation (from $24\%$ to $20\%$ on the first $2.5 million).
- Tier 2 Marginal Loss: A loss of $\$100,000$ due to the 4-point drop (from $15\%$ to $11\%$) on the remaining $\$2.5$ million of excess QREs ($4\% \times \$2.5\text{M} = \$100,000$).
Section 6: Strategic Financial Planning Implications
The scheduled rate reduction and the simultaneous shortening of the carryforward period necessitate immediate re-evaluation of long-term tax planning strategies for Arizona-based R&D activities.
Optimizing the Base Amount Under Compressed Rates
Since the credit percentage is decreasing, the calculation method chosen to determine the Base Amount becomes relatively more impactful on the final credit value. Taxpayers calculate their credit using either the Regular Method (Fixed-Base Percentage applied to average gross receipts) or the Alternative Simplified Credit (ASC) Method (50% of the average QREs over the prior three years).1 The goal is to maximize the amount of “excess QREs.” A marginal percentage point change in the Base Amount results in a larger change in the final dollar credit when the incentive rates (20% and 11%) are lower, thus heightening the importance of precise base optimization through careful method selection and documentation.
Temporal Strategy and Base Inflation
R&D tax planning requires managing an inter-temporal trade-off due to the incremental nature of the credit. By accelerating significant R&D activity into Tax Year 2030, a company maximizes the credit received under the higher 24%/15% rates. However, this high expenditure in 2030 will subsequently inflate the Base Amount used in the calculation for 2031 and future years, potentially through 2034, depending on the Base Amount methodology used.1
This Base Amount inflation means that the benefit gained from the high 2030 rates may be partially negated by a reduced ability to generate “excess QREs” under the lower 20%/11% rates in future years. Strategic planners must quantify the net present value of the higher 2030 credit compared to the cumulative future credit reduction resulting from the artificially inflated base, ensuring that the short-term gain does not result in a greater long-term loss.
Managing Carryforward and Utilization Risk
The reduction of the credit carryforward period from 15 years to 10 years for credits generated after 2021 creates a complex credit utilization hierarchy.7 Companies must establish rigorous accounting procedures to track the expiration clock of both the 15-year carryforwards (pre-2022) and the newer, shorter 10-year carryforwards (post-2021). To manage expiration risk effectively, strategic utilization should prioritize utilizing credits with the shortest remaining life first, maximizing the lifespan of the accrued, high-rate benefits.
Competitive Implications
The scheduled reduction in credit rates diminishes Arizona’s relative competitiveness in attracting and retaining large-scale R&D investment compared to states that maintain more generous or uncapped incentives. The state’s R&D ranking among states (in terms of dollars spent) has already been declining, dropping from 18th in 2015 to 21st in 2020.16 CFOs and strategic development teams must integrate the reduced 20%/11% incentive into future capital allocation decisions, potentially favoring jurisdictions with higher marginal returns or more stable long-term credit structures.
Conclusion
The transition to the 20% Tier 1 R&D tax credit rate in Arizona, effective January 1, 2031, is not a minor adjustment but a structural erosion of the state’s R&D incentive package. This shift, coupled with the reduction in the credit carryforward period, signals a tightening of state policy regarding future tax expenditures. For taxpayers, this requires immediate, high-fidelity modeling to capture the fixed $\$100,000$ reduction in the Tier 1 benefit and the severe drop in the marginal return on R&D investment above the $\$2.5$ million threshold. Compliance requires heightened vigilance regarding the ACA certification mandate and the inevitable administrative changes to ADOR tax forms in 2031. Strategic financial planning must focus heavily on the inter-temporal trade-off between maximizing the higher current rates and minimizing the subsequent inflation of the base amount under the lower future rates, ensuring the optimization of the remaining ten-year carryforward period.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
